Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001185185-21-000786
Filing Date
2021-06-08
Accepted
2021-06-08 16:51:57
Documents
39
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q amgreat20191231_10q.htm 10-Q 307244
2 EXHIBIT 31.1 ex_255557.htm EX-31.1 8718
3 EXHIBIT 32.1 ex_255558.htm EX-32.1 4518
  Complete submission text file 0001185185-21-000786.txt   1496162

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT aagh-20191231.xml EX-101.INS 124060
5 XBRL TAXONOMY EXTENSION SCHEMA aagh-20191231.xsd EX-101.SCH 17294
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aagh-20191231_cal.xml EX-101.CAL 17219
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aagh-20191231_def.xml EX-101.DEF 89575
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE aagh-20191231_lab.xml EX-101.LAB 145457
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aagh-20191231_pre.xml EX-101.PRE 93669
Mailing Address 1609 W VALLEY BLVD UNIT 338A ALHAMBRA CA 91803
Business Address 1609 W VALLEY BLVD UNIT 338A ALHAMBRA CA 91803 (626) 576-1299
America Great Health (Filer) CIK: 0001098009 (see all company filings)

EIN.: 980178621 | State of Incorp.: CA | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-27873 | Film No.: 211002722
SIC: 2834 Pharmaceutical Preparations